What is the difference in survival between tacrolimus and cyclosporine in liver transplant patients?

Updated: Dec 31, 2017
  • Author: Lemi Luu, MD, RDMS, FACEP, FAAEM; Chief Editor: Barry E Brenner, MD, PhD, FACEP  more...
  • Print


In general, tacrolimus and cyclosporine are fairly similar in terms of graft and patient survival. However, rates of graft rejection are lower and the need for steroids is less when tacrolimus is used.

When used as part of telaprevir-based triple-drug therapy for posttransplantation HCV recurrence, daily low-dose tacrolimus appears to be a safe and effective immunosuppressive regimen. [12]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!